1 / 32

Carbox y Therapy

Carbox y Therapy. CARBOXITHERAPY. What is it?. It is a non surgical method which consists of injecting CO2 at subcutaneous level through a very fine needle (3mm) by using an equipment especially designed for regulating the gas exit with a low pressure. Characteristics of CO2.

blair-eaton
Download Presentation

Carbox y Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Carboxy Therapy

  2. CARBOXITHERAPY What is it? It is a non surgical method which consists of injecting CO2 at subcutaneous level through a very fine needle (3mm) by using an equipment especially designed for regulating the gas exit with a low pressure.

  3. Characteristics of CO2 • Non scent, colorless, soluble in water • Final product of the organic metabolism • High disolution ( 20 times more than O2 in the microcirculation) • Modest transformation in HCO3

  4. Origen of Carboxitherapy • 1930 : France . Gas de Royat. Arteriopaties • 1930 : Argentine Medical Association • 1953: Publication of 20 experienced years with subcutaneous injections

  5. Action mecanisms. • Active Vaso-dilatation • Increment of oxidatve phenomena • Arteriolization of blood (Bohr effect) • Increasing of cellular oxygenation • Lipolitic effect • Sympatic-litic effect

  6. Toxicity • Absence of toxicity with high dose • Absence of increment in the systemic TA • No variations in the systemic partial pressure of O2 and CO2

  7. Medical directions • Angiology: Arteriopaties, microangiopaties • Reumatology: Arthritis • Urology: Erectil disfunction by angiopaties • Dermatology: Psoriasis, ulcers related to microangiopaties.

  8. Therapeutic directions • Vascular and artery pathologies • Acute arthritis • Sports Medicine • Healing defects

  9. Aesthetic indications • Cellulitis • Located adiposity • Pre liposculpture • Pos lipoescuplture

  10. Contraindications • IAM, unstable anginas • ICC • HTA • Acute tromboflebitis • Located Infections • Epilepsy • Pregnancy • Renal and respiratory insufficiencies

  11. Treatment sessions Between 15 and 20 sessions of approximately 10 minutes each, are suggested according to the different cases. The intensity per week is 2 or 3.

  12. Treatment protocol • The suggested dose of CO2 per member should oscillate between 100 and 200 cc. • Divide the treated zone into 4 or 6 quadrants in eah member. It is suggested not to inject more than 30 o 50 cc per zone. • It is convenient to jab in several directions. • Injections should be complemented with manual massages to spread the gas, control the efisema and dicrease the annoyance on the patient

  13. Patient with multiple symmetrical lipomatosis; pre-surgery situation (frontal) Patient with multiple symmetrical lipomatosis; pre-surgery situation (lateral) Clinic cases

  14. . Patient with multiple symmetrical lipomatosis; pos-surgery situation (frontal) Patent with multiple symmetrical lipomatosis; pos surgery situation (lateral) Clinic cases

  15. Figure1. Microphotograph of the abdominal subcutaneous weave on the patient with multiple symmetrical lipomatosis : biopsy before the treatment with CO2 Figure 2. Microphotography of the abdominal subcutaneous weave on the patient with multiple symmetrical lipomatosis : biopsy after the treatment with CO2. The areas of lisis adipocitaries are evident, with conservation of the anatomic integrity of the vascular system. Microphotograph

  16. Bibliography • Hartmann B.R., Bassenge E., Pittler M.: «Effect of carbon dioxide enriched water on the cutaneous mícrocirculation and oxygen tension in the skin of the foot». Angiology, 48, 957, 1997. • Klopstock T., Naumann M., Seibel P., et al.: «Mitocondrial DNA mutations in multiple Symmetric lipomatosis». Mol. Cell. Biochem., 17, 271, 1997. • Savin E., Bailliart O., Bonnin P., et al.: «Vasomotor effects of transcutaneous CO2 in stage. Il peripheral occlusive arterial disease». Angiology, 46, 785, 1995. • Smith P.D., Stadelmann W.K., Wassemann R.J., et al.: «Benign symmetric lipomatosis (Madelung's disease)». Ann. Plast. Surg., 41, 671, 1998. • Stavropoulos P.G., Wouboulis C.C., Trautmann C., et al.: «Symmetric lipomatoses in female patients». Dermatology, 194, 26, 1997.

  17. THANKS FOR YOUR ATENTION

More Related